STEMETIL

This brand name is authorized in Australia, Cyprus, Estonia, Finland, Hong Kong SAR China, Ireland, Malta, New Zealand, Singapore, UK.

Active ingredients

The drug STEMETIL contains one active pharmaceutical ingredient (API):

1	Prochlorperazine UNII I1T8O1JTL6 - PROCHLORPERAZINE MALEATE
	Prochlorperazine belongs to the phenothiazine group. Prochlorperazine has a wide range of activity arising from its depressant actions on the CNS and its alpha-adrenergic blocking and weaker anti-muscarinic properties. It inhibits dopamine and prolactin-release-inhibitory factor, thus stimulating the release of prolactin.
	Read more about Prochlorperazine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
STEMETIL Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
STEMETIL Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AB04	Prochlorperazine	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AB Phenothiazines with piperazine structure
Discover more medicines within N05AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2369Q, 2893G, 3477B, 5205Y, 5206B
EE	Ravimiamet	1615025
FI	Lääkealan turvallisuus- ja kehittämiskeskus	160523
GB	Medicines & Healthcare Products Regulatory Agency	144022, 14541, 162500, 181502, 23063, 27606
HK	Department of Health Drug Office	31117
IE	Health Products Regulatory Authority	47090, 61123, 61131, 61875
MT	Medicines Authority	AA770/05302
NZ	Medicines and Medical Devices Safety Authority	1991
SG	Health Sciences Authority	01382P